Service & Suppliers

Found 21,058 articles

• Nanoform's Clinical Study Indicates Positive Interim Results - Jan 22, 2021

  1/22/2021

  Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, announced positive interim results from its clinical study.

• DWHP Announces Extension of The Expiration Time of Its Tender Offer

  1/22/2021

  DW Healthcare Partners V, L.P., announced that it is extending the expiration time of its previously announced cash tender offer in the Offer to Purchase dated December 21, 2020 for all of the outstanding ordinary shares of Parnell Pharmaceuticals Holdings Ltd at a price of U.S.$0.40 per share, net to the seller in cash without interest and less applicable withholding taxes to 11:59 p.m., New York City time, on January 28, 2021.

• Conference call Report on Operations 2020: Vitrolife

  1/22/2021

  Invitation to attend Vitrolife's conference call regarding presentation of the Report on Operations 2020.

• Worldwide Clinical Trials Moves Headquarters to Research Triangle Park

  1/21/2021

  Worldwide Clinical Trials, Inc., an award-winning, full-service, midsize, global CRO, has moved its corporate headquarters from Morrisville, N.C., to Frontier RTP, the innovation campus located in the heart of Research Triangle Park in North Carolina.

• MJ Biotech, Inc. (MJTV), Subsidiary, Joint Venture Partner Genesis Botanical Research, Begins Construction of CBD Extraction Facility

  1/21/2021

  MJ Biotech Inc. is pleased to announce that it's subsidiary New England Biotech's partner Genesis Botanical, has begun construction of the CBD Extraction facility after securing a location.

• Medolife Rx, Inc. Has Submitted Applications Of Their Scorpion Venom To Help Fight Against Cancer And COVID-19 With The FDA In The Dominican Republic;

  1/21/2021

  The FDA Is In The Process Of Investigation And Conducting Their Due Diligence For Efficacy And Safety

• Binovi Technologies Q3 2020 Revenue Up, Increasing Top-Line and Gross Margin Results

  1/21/2021

  Binovi Technologies Corp. a leader in neuro-vision performance technology, reports results for the Company's fiscal third quarter, ended November 30, 2020.

• Federal PMPRB Drug Pricing Rules Already Stopping What Canadians Want: Access to New Cancer Medicines and Other Treatments as Soon as Possible

  1/21/2021

  Survey of pharmaceutical executives confirms almost all companies will delay new product launches; more than one-third already have

• Vast Majority of Pharmacists Plan to or Have Been Vaccinated Against COVID-19, APhA Survey Finds

  1/21/2021

  More than 9 in 10 pharmacists said they plan to or have been vaccinated against COVID-19, in a survey conducted last week by the American Pharmacists Association.

• Editas Medicine Announces Pricing of Offering of Common Stock - Jan 21, 2021

  1/21/2021

  Editas Medicine, Inc., a leading gene editing company, announced the pricing of an underwritten offering of 3,500,000 shares of its common stock at a public offering price of $66.00 per share, before deducting underwriter discounts and commissions and estimated offering expenses.

• China Jo-Jo Drugstores Hosts the First Suppliers Conference in China - Jan 21, 2021

  1/21/2021

  China Jo-Jo Drugstores, Inc., a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, announced that the Company hosted its first suppliers conference in Haiwaihai International Conference Center of Hangzhou, China at the end of December 2020, which was attended by approximately 200 representatives of its suppliers.

• Inhibitory effect on the novel coronavirus (SARS-CoV-2) confirmed through testing of Panasonic's air conditioners with nanoe™ X technology

  1/21/2021

  Panasonic Corporation announced on January 14, 2021, that the inhibitory effect on the novel coronavirus of a representative Panasonic air conditioner equipped with nanoe™ X*1 was verified by Texcell*2, a global contract research organization.

• Nolan Chang, MD, appointed to National Permanente Leadership Team

  1/21/2021

  Proven physician leader to assume a wide range of governance and leadership responsibilities on behalf of 8 Permanente Medical Groups

• Cerner Names New Chief Financial OfficerMark Erceg Brings Multi-Dimensional Experience to Health Care Technology Leader

  1/21/2021

  Cerner Corporation, a global health care technology company, announced that Mark Erceg will join the company as Executive Vice President and Chief Financial Officer, effective February 22, 2021.

• Microbot Medical Enhances Scientific Advisory Board with World Renowned Interventional RadiologistsScientific Advisory Board Expanded with Additions of Global Medical Pioneers and Distinguished Thought Leaders

  1/21/2021

  Microbot Medical Inc. continues to enhance its thought leadership capabilities with the addition of several new Scientific Advisory Board members: Stephen B. Solomon, MD, a board-certified radiologist with clinical expertise in Interventional Radiology with a focus in Tumor Ablation; Ajay K.

• DarioHealth Announces Hiring of Leading Digital Health Innovator as Senior Vice President of Employer Sales

  1/21/2021

  DarioHealth Corp., a pioneer in the global digital therapeutics market, announced the appointment of Chris Chan as Senior Vice President of Employer Sales.

• Conformis, Inc. and SITES Medical Announce Development & Supply Agreement

  1/21/2021

  Conformis, Inc. (NASDAQ:CFMS) and SITES Medical, a firm dedicated to inventing and de-risking new orthopedic medical device technologies, today announced they have entered into a non-exclusive development and supply agreement. The companies will work together to incorporate SITES Medical’s proprietary OsteoSync Ti Technology into future Conformis’ cementless total knee replacement products. “We are excited to be part

• Aviva Pharmacy Provides Initial Doses of COVID-19 Vaccine

  1/21/2021

  Aviva Pharmacy, an independent pharmacy located in Long Beach, CA has announced that it has obtained supplies of both the Moderna and Pfizer COVID-19 vaccines and has begun administering vaccinations to health care providers and those 65 years of age or older in Long Beach.

• Avantor® Declares Dividend on Mandatory Convertible Preferred Stock - Jan 21, 2021

  1/21/2021

  Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced that its Board of Directors has declared a quarterly cash dividend to holders of its 6.250% Series A Mandatory Convertible Preferred Stock of $0.78 per share at a rate per share of 1.560%, payable on February 15, 2021 to holders of record on February 1, 2021.

• Intuitive Announces Fourth Quarter 2020 Earnings

  1/21/2021

  Intuitive, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced financial results for the quarter ended December 31, 2020.